Paid Clinical Trials Vancouver

Discover 508 paid clinical trials in Vancouver, British Columbia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 508

Observational StudyPancreatic Cancer Early Detection Consortium

Recruiting

Sponsor:

Arbor Research Collaborative for Health

Location:

Vancouver, Seattle WA, Portland OR, Sacramento CAshow 39 more

Code:

NCT04970056

Conditions

Pancreas Cancer

Pancreas Cyst

Pancreatic Ductal Adenocarcinoma

Genetic Predisposition

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Accepted

BMS-986340, Nivolumab, DocetaxelA Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors

Recruiting

PHASE1

PHASE2

Sponsor:

Bristol-Myers Squibb

Location:

Vancouver, Portland OR, Edmonton, Clovis CAshow 11 more

Code:

NCT04895709

Conditions

Cervical Cancer

Gastric/Gastroesophageal Junction Adenocarcinoma

Microsatellite Stable Colorectal Cancer

Non-Small-Cell Lung Cancer

Squamous Cell Carcinoma of Head and Neck

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

BMS-986340

BMS-936558-01

Docetaxel

Clinical Prediction ModelsUsing Clinical Prediction Models to Improve Treatment for Patients With Chronic Obstructive Pulmonary Disease (COPD)

Recruiting

Sponsor:

University of British Columbia

Location:

Vancouver

Code:

NCT05309356

Conditions

Chronic Obstructive Pulmonary Disease

Eligibility Criteria

Sex: All

Age: 35+

Healthy Volunteers: Not accepted

Interventions

ACCEPT Decision Intervention

Comparator

CranberryCranberry for the Prevention of Urinary Tract Infections

Recruiting

Sponsor:

University of British Columbia

Location:

Vancouver

Code:

NCT02454309

Conditions

Urinary Tract Infection

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Accepted

Interventions

Cranberry concentrate

Placebo

Observational StudyVascular Complications in Children From T1D Diagnosis

Recruiting

Sponsor:

University of British Columbia

Location:

Vancouver

Code:

NCT05790785

Conditions

Type 1 Diabetes

Cardiovascular Complications

Child

Adolescent

Eligibility Criteria

Sex: All

Age: 8 - 17

Healthy Volunteers: Not accepted

AnifrolumabA 2-stage, Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus Erythematosus

Recruiting

PHASE3

Sponsor:

AstraZeneca

Location:

Vancouver, Seattle WA, Portland OR, Edmontonshow 43 more

Code:

NCT06015737

Conditions

Cutaneous Lupus Erythematosus

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Interventions

Anifrolumab

Placebo

Pharmacogenomic TestingIntegrating Pediatric Pharmacogenomic Testing Into the Canadian Health Care System

Recruiting

Sponsor:

University of British Columbia

Location:

Vancouver, Ottawa

Code:

NCT04249375

Conditions

Adverse Drug Reaction (ADR)

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Urine DNA TestingProspective Validation Study of High Volume Urine DNA Testing in Individuals with Suspicion of Urothelial Cancer

Recruiting

Sponsor:

Tampere University Hospital

Location:

Vancouver, Chicago IL

Code:

NCT06310759

Conditions

Urothelial Carcinoma

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Observational StudyEarly Ileostomy Closure for Rectal Cancer Patients in North America

Recruiting

Sponsor:

Jewish General Hospital

Location:

Vancouver, London, Montreal

Code:

NCT05027737

Conditions

Ileostomy - Stoma

Rectal Cancer

Eligibility Criteria

Sex: Female

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Early Ileostomy Closure

Transcutaneous Spinal Cord StimulationTranscutaneous Spinal Cord Stimulation Home Study

Recruiting

Sponsor:

Michael Berger

Location:

Vancouver

Code:

NCT06838637

Conditions

Spinal Cord Injuries

Multiple System Atrophy, Parkinson Variant

Eligibility Criteria

Sex: All

Age: 19 - 70

Healthy Volunteers: Not accepted

Interventions

Spinal COrd NEuromodulation ("SCONE") Device